tiprankstipranks
BioCardia completes last protocol specified follow-up visit in CardiAMP HF
PremiumThe FlyBioCardia completes last protocol specified follow-up visit in CardiAMP HF
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BioCardia regains full compliance with Nasdaq listing rules
Premium
The Fly
BioCardia regains full compliance with Nasdaq listing rules
3M ago
BioCardia announces FDA approved amendment for CardiAMP trial
PremiumThe FlyBioCardia announces FDA approved amendment for CardiAMP trial
4M ago
BioCardia price target adjusted to $25 from $4 at H.C. Wainwright
Premium
The Fly
BioCardia price target adjusted to $25 from $4 at H.C. Wainwright
4M ago
BioCardia submits for FDA approval of Morph DNA Steerable Introducer family
Premium
The Fly
BioCardia submits for FDA approval of Morph DNA Steerable Introducer family
5M ago
BioCardia’s ProtheraCytes Phase II Success Promises Future Growth
PremiumCompany AnnouncementsBioCardia’s ProtheraCytes Phase II Success Promises Future Growth
6M ago
BioCardia, CellProthera collaborate on Phase II trial of ProtheraCytes
Premium
The Fly
BioCardia, CellProthera collaborate on Phase II trial of ProtheraCytes
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100